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We show that mice with a targeted deficiency in the
gene encoding the lipogenic transcription factor
SREBP-1a are resistant to endotoxic shock and
systemic inflammatory response syndrome induced
by cecal ligation and puncture (CLP). When macro-
phages from the mutant mice were challenged with
bacterial lipopolysaccharide, they failed to activate
lipogenesis as well as two hallmark inflammasome
functions, activation of caspase-1 and secretion of
IL-1b. We show that SREBP-1a activates not only
genes required for lipogenesis in macrophages but
also the gene encoding Nlrp1a, which is a core
inflammasome component. Thus, SREBP-1a links
lipid metabolism to the innate immune response,
which supports our hypothesis that SREBPs evolved
to regulate cellular reactions to external challenges
that range from nutrient limitation and hypoxia to
toxins and pathogens.
INTRODUCTION
Individual cells monitor their surrounding environment and react
to extracellular challenges that require adaptation or threaten
viability. The lipid-rich plasma membrane forms a barrier
between a cell and its surroundings and participates in the initial
response to changes in nutrient availability and chemical or bio-
logical attack. The lipids of the membrane bilayer are key to the
dynamics of all cell-environment interactions, and regulation of
lipid concentration and composition is essential to optimize
protein-lipid microenvironments required for transport,
signaling, internalization, and shape alterations such as blebbing
and invagination. A reliable supply of lipids is essential for each of
these functions; thus, the regulation of lipid levels is fundamen-
tally critical for cell-environment interactions.
The sterol regulatory element binding proteins (SREBPs) are
a small family of bHLHLZ transcription factors that were first540 Cell Metabolism 13, 540–549, May 4, 2011 ª2011 Elsevier Inc.identified in mammalian cells as key regulators of cellular lipid
levels (Horton et al., 2002; Osborne and Espenshade, 2009).
They are conserved from fission yeast to humans, and there is
emerging evidence that in addition to regulating lipidmetabolism
in response to nutrient levels, SREBPs may play roles in
responses to other environmental challenges (Osborne and
Espenshade, 2009). These range from oxygen sensing in
S. pombe (Hughes et al., 2005), responding to pore-forming
bacterial toxins in mammalian fibroblasts (Gurcel et al., 2006)
and intestinal adaptations to limit absorption of bitter-tasting
toxic dietary components (Jeon et al., 2008).
There are three major mammalian SREBP isoforms: two en-
coded by the Srebf-1 gene through a combination of alternative
promoters and differential splicing, and one encoded by the
Srebf-2 gene (Osborne and Espenshade, 2009). In general,
SREBP mRNAs are ubiquitously expressed, but their ratios
vary across different tissues. For example, SREBP-1c, an essen-
tial regulator of the hepatic insulin response, is ten times more
abundant than SREBP-1a in the liver (Horton et al., 1998; Kim
et al., 1998).
In contrast, SREBP-1a is the major isoform in all cultured cell
lines examined (Shimomura et al., 1997), and our current studies
show it is the most abundant SREBP-1 species in macrophages
(Figure 1). Based on this observation and the expanding role of
SREBPs in environmental sensing, we hypothesized that
SREBP-1a may directly participate in a primary role of macro-
phages such as pathogen engagement. This is also supported
by earlier studies with cultured fibroblast cell lines that indicated
SREBPs are activated after exposure to pore-forming bacterial
toxins (Gurcel et al., 2006) and during phagocytosis of latex
beads (Castoreno et al., 2005).
Here, we show that mice with a targeted deficiency that
specifically inactivates SREBP-1a are resistant to the toxic
effects of both lipopolysaccharide (LPS) challenge and sepsis
following cecal ligation and puncture (CLP), consistent with
a defective innate immune response. Investigating the mecha-
nism in cultured macrophages, we show that SREBP-1a mutant
macrophages secrete reduced IL-1b because they have a defect
in expression of Nlrp1a which is an NLR family protein that
contains both NACHT and leucine-rich repeats (LRRs) (Franchi
Figure 1. Tissue Patterns for SREBP mRNA Expression
Tissue survey for SREBP-1 and SREBP-1c: total RNA from the indicated
tissues was used for qPCR with an internal control DNA standard for quanti-
tation. Values are presented as fg of RNA/mg total RNA. Data are from pooled
RNA samples from WT and SREBP-1aDF (n = 9/group). SR-1a and SR-1c
correspond to SREBP-1a and SREBP-1c, respectively. Abbreviations for
different tissues are as follows: BAT, brown adipose; ING, inguinal white fat;
GON, gonadal white fat; DUOD, duodenum; BMDM, bone marrow-derived
macrophage; PTM, peritoneal-derived thioglycholate elicited macrophage;
BMDC, bone marrow dendritic cell.
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caspase-1 as part of an inflammasome (Franchi et al., 2009;
Martinon et al., 2007; Schroder and Tschopp, 2010) to cleave
proinflammatory cytokines IL-1b and IL-18 before their secretion
(Martinon et al., 2007; Schroder and Tschopp, 2010). We also
show SREBP-1a directly activates the Nlrp1a gene and LPS
stimulates lipogenesis through an SREBP-1a-dependent
mechanism. Thus, SREBP-1a couples lipogenesis with the
macrophage innate immune response.RESULTS
SREBP-1a Is Abundantly Expressed in Macrophages
We have generated a mouse line with an insertion of a b-geo
expression cassette into the intron between the two alternative
50 exons of the mouse SREBP-1 gene (see Figure S1 available
online). The insertion significantly reduces normal splicing
required from the most 50 exon containing the longer and more
potent SREBP-1a activation domain but has no effect on expres-
sion from the other promoter responsible for generating the
weaker SREBP-1c isoform (Im et al., 2009). The resulting
SREBP-1a-deficient mice (SREBP-1aDF) are viable and mani-
fest a mild hepatic defect during fasting (Im et al., 2009).
SREBP-1a is expressed at a far lower level relative to SREBP-
1c in liver (Shimomura et al., 1997), so themild hepatic phenotype
was not surprising. To identify a tissue where loss of SREBP-1a
might be more consequential, we surveyed multiple tissues to
determine where it is the predominant isoform. We analyzed
serial dilutions of plasmidDNA in parallel in these studies,making
it possible to define isoform-specific expression patterns in
a quantitative fashion. Interestingly, the absolute levels of the
transcripts, and the ratios of SREBP-1a and -1c, varied dramat-
ically across several adult tissues (Figure 1). In particular,CSREBP-1a mRNA was very high, and much more abundant
than SREBP-1c, in macrophages cultured from bone marrow
(BMDM) or elicitied from the peritoneal cavity after an injection
of thioglycolate (PTDM). Bone marrow dendritic cells (BMDCs),
heart, and small intestine also expressedmostly the 1amessage.
SREBP-1aDF Mice Are Resistant to Proinflammatory
Toxic Shock
Macrophages play a key role in the innate immune response to
pathogen challenge, so we tested the hypothesis that SREBP-
1aDF mice might have an impaired innate immune response
using three different in vivomodel systems to evaluate responses
to pathogen engagement. In the first model, we challenged the
mice with injection of the bacterial outer membrane component
LPS. LPS induces a robust inflammatory response in mice, and
high doses are lethal (Ianaro et al., 2009). The SREBP-1aDF
mice exhibited significant protection from the toxic effects of
LPS relative to control mice (Figure 2A; p = 0.03). These results
suggest that the SREBP-1aDFmicemight have a reduced proin-
flammatory response, so we measured the serum levels of
several proinflammatory cytokines. Serum levels of IL-1b were
dramatically lower in the SREBP-1aDF mice (Figure 2B), and
IL-12 was the only other cytokine that had significantly lower
levels relative to WT (Figure S2).
To further explore the in vivo effect of SREBP-1a deficiency on
the innate immune system, we assessed the response of
SREBP-1aDF mice to induction of polybacterial sepsis following
a CLP protocol (Rittirsch et al., 2009). In this experimental model
of generalized sepsis (Remick and Ward, 2005), the cecum is
punctured allowing intestinal bacteria to enter the peritoneal
cavity, and mice typically die as a consequence of the resulting
systemic inflammatory response syndrome (SIRS). The
SREBP-1aDF mice also showed enhanced survival relative to
WT mice after CLP (Figure 2C). Interestingly, serum levels of
IL-1b were also dramatically reduced in the SREBP-1aDF mice
following the CLP (Figure 2D). The reduced levels of proinflamm-
tory IL-1b are consistent with the enhanced survival in both of
these hyperinflammatory model systems.
Protection from oral infection by bacterial pathogens such as
S. typhimurium requires a normal proinflammatory response,
and we hypothesized that the SREBP-1aDF mice might be
more susceptible to bacterial infection by this route. When WT
and SREBP-1aDF mice were challenged with an oral dose of
S. typhimurium, there was increased inflammatory cell infiltra-
tion, especially neutrophils, into the cecum of the SREBP-1aDF
mice (Figures 2E and 2F) despite lower levels of bacterial coloni-
zation (Figure 2G). Consistent with the pathological assessment,
expression of the neutrophil selective chemokine CXCL1 was
also signficantly increased in the SREBP-1aDF cecum
(Figure 2H).
SREBP-1aDF Macrophages Have Reduced SREBP-1
Protein Levels
The in vivo responses to LPS, CLP, and S. typhimurium are
consistent with an impaired innate immune response, and
because SREBP-1a is abundantly expressed in macrophages
(Figure 1), we evaluated a potential mechanism for the in vivo
responses through studies in cultured macrophages. First, we
showed that SREBP-1a mRNA was dramatically reduced inell Metabolism 13, 540–549, May 4, 2011 ª2011 Elsevier Inc. 541
Figure 2. Role of SREBP-1a in Inflammatory Signaling in Mice
(A) Survival curves for WT or SREBP-1aDF mice after i.p. injection with LPS
(10mg/kg). Animals weremonitored over 7 days after LPS injection, WT versus
1aDF p = 0.0308.
(B) Serum IL-1b levels were analyzed by ELISA, *WT versus 1aDF after LPS
treatment, p = 0.0007.
(C and D) WT or SREBP-1aDF mice (n = 10) underwent CLP using one
puncture from a 23 gauge needle. (C) Survival curves for WT or SREBP-1aDF
Cell Metabolism
SREBP-1a, Lipids, and Innate Immunity
542 Cell Metabolism 13, 540–549, May 4, 2011 ª2011 Elsevier Inc.the SREBP-1aDF macrophages without significant effects on
expression of the other SREBPs (Figure 3). Immunoblotting
with an antibody that reacts with both SREBP-1 isoforms re-
vealed that the level of nuclear SREBP-1 protein was also
reduced (Figure 3D). Because the level of 1c mRNA was not
reduced, we can conclude that the major SREBP-1 protein in
BMDM is SREBP-1a.
SREBP-1a Activates Genes Encoding Inflammasome
Subunits in Macrophages
To search for a phenotypic difference in SREBP-1aDF macro-
phages, we first compared global mRNA expression patterns
in BMDM isolated from WT and SREBP-1aDF mice. The genes
that exhibited statistically significant changes in gene expression
of 1.5-fold or higher are highlighted in Figure 4A. The expression
of two genes, Nlrp1a and Nlrp1c, were reduced over 95% in the
SREBP-1aDF macrophages, which was even more dramatic
than the effect on expression of SREBP-1 itself (Figure 4B).
This finding was confirmed by gene-specific quantitative real-
time polymerase chain reaction (qPCR) analysis (Figure 4C).
We analyzed expression of mRNAs for the related Nlrp1b,
Nlrp3, Nlrc4, and ASC as well as IL-1b (Figure 4B and Figure S3),
and none were affected by the loss of SREBP-1a.
Nlrp1a and -1c encode nucleotide oligomerization domain and
leucine-rich repeats receptor family members (NOD/LRR)
(Franchi et al., 2009; Martinon et al., 2007). These particular
NOD/LRRs are predicted to function as scaffold components
of an inflammasome, which is a multisubunit complex(es) that
stimulates caspase-1 to cleave proinflammatory cytokines pro
IL-1b, pro IL-18, and possibly pro IL-33 (Franchi et al., 2009) to
produce the mature inflammatory cytokines. IL-1b and IL-18
are released from macrophages as part of the proinflammatory
response to bacterial engagement through Toll-like receptor
4 (TLR4) signaling (Kaisho and Akira, 2000). This is a primary
macrophage innate immune response to microbial pathogens,
and our in vivo results would be consistent with reduced in-
flammsome activity in the SREBP-1aDF macrophages.
Inflammasome Activity Is Compromised in SREBP-1aDF
Macrophages
To evaluate whether SREBP-1aDF macrophages have impaired
inflammasome function, we performed comparative studies inmice after CLP surgery, WT-CLP versus 1aDF-CLP, p = 0.0015 by Mantel-
Haenszel log rank test. (D) Bloodwas collected after 24 hr and serum IL-1bwas
measured. **WT-CLP versus 1aDF-CLP after 24 hr, p = 0.0082. WT-sham,
sham laparotomy with WT mice; WT-1p, one puncture in cecum of WT;
SREBP-1aDF-sham, SREBP-1aDF sham laparotomy; SREBP-1aDF-1p, one
puncture in cecum of SREBP-1aDF mice.
(E) H & E staining of cecal sections from S. typhimurium-infected mice; arrows
denote areas of neutrophil infiltration that is shown at a highermagnification for
the inset region as noted.
(F) Pathology assessment and inflammation scores: color code for bar
symbols is as follows: blue, neutrophils; maroon, mononuclear infiltrate; green,
submucosal edema; purple, surface erosions; light blue, inflammatory
exudate; orange, cryptitis.
(G) Cecal S. typhimurium colonization (colony-forming units/mg of tissue,
CFU/mg) at 72 hr postinoculation, p = 6.5 3 e6.
(H) CXCL1 mRNA in S. typhimurium-infected cecummeasured by qPCR. #WT
versus 1aDF, p = 0.0006.
Figure 3. SREBP Expression Levels in BMDM of WT and SREBP-
1aDF Mice
Total RNA was isolated from BMDM and equal amounts of RNA were used for
the quantitative RT-PCR assay. RNA expression levels for SREBP-1a (A),
SREBP-1c (B), and SREBP-2 (C) are shown as the quantitative expression
levels calculated by comparison to qPCR values obtained with a standard
curve of serially diluted linear plasmid cDNA. The data are plotted as femto-
grams of RNA normalized to ribosomal L32 samples analyzed in parallel. Bars
represent the standard deviations. (D) Nuclear SREBP-1 protein level. Nuclear
protein was prepared from BMDM of WT and SREBP-1aDF mice. Aliquots
(30 mg) were analyzed by immunoblotting for SREBP-1. *p = 0.0031, indicating
a statistically significant difference between BMDM from the two lines of mice.
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LPS-dependent increase in caspase-1 activity in WT macro-
phages was blunted in SREBP-1aDF cells (Figure 5A). To
measure IL-1b production frommousemacrophages, a prechal-
lenge with LPS followed by an acute treatment with an additonal
exogenous signal such as ATP is typically required (Mariathasan
et al., 2004; Sutterwala et al., 2006). Figure 5B shows that the
increase in IL-1b release observed in WT was significantly
reduced in the SREBP-1aDF macrophages. Caspase-1 mRNA
levels as well as IL-1b mRNA induction by LPS were not altered
(Figure S4), so the results are consistent with reduced caspase-1
activation and confirm that the SREBP-1aDFmacrophages have
impaired inflammasome function.
IL-1b production in response to S. typhimurium infection was
also reduced in the SREBP-1aDF macrophages (Figure 5C) as
well, which is consistent with a defective inflammasome
response. Because serum levels of IL-12 were also lower in the
SREBP-1aDF mice treated with LPS (Figure S2), we also
measured IL-12 mRNA and production of extracellular IL-12
cytokine. The mRNA levels for both subunits as well as the
secreted IL-12 cytokine were also lower in the SREBP-1aDF
samples (Figures S4E–S4G).
IL-1b secretion in response to LPS plus ATP was also reduced
in Nlrp3/ macrophages, and the corresponding mice were
protected from lethal challenge by LPS injection (Sutterwala
et al., 2006). Both of these responses are similar to the results re-
ported here for the SREBP-1aDF mice. To compare the roles ofCNlrp1a and Nlrp3 in LPS-dependent IL-1b secretion, we used an
siRNA approach to reduce expression of each Nlrp inWTmacro-
phages, and the results in Figure 5D demonstrate that both
Nlrp1a and Nlrp3 contribute to IL-1b secretion and the effects
may be additive. RNA expression studies confirmed that each
Nlrp was specifically targeted by the corresponding siRNA
(Figures 5E and 5F).
The siRNA results also indicate that the reduced inflamma-
some activity in the SREBP-1aDF macrophages is unlikely to
result from the loss of another SREBP-1a-dependent process.
Additionally, when SREBP-1a expression was restored in the
mutant macrophages by electroporation, that LPS-dependent
IL-1b secretion was also restored (Figure 5G). Thus, the reduced
inflammasome activity in the SREBP-1aDFmacrophages results
from reduced Nlrp1a.Nlrp1a Is a Direct SREBP-1a Target Gene
To determine whether Nlrp1a or Nlrp1cmight be gene targets for
SREBP-1a, we reintroduced SREBP-1a by adenovirus infection
into the SREBP-1aDF macrophages, and expression of Nlrp1a,
but not Nlrp1c, returned to normal levels (Figure 6A). We also
showed that SREBP-1 both activates the promoter through
a region containing a canonical SREBP-1 binding site in trans-
fection assays (Figures 6C–6E) and binds to the Nlrp1 gene-
proximal promoter by ChIP analysis (Figures 6F and 6G). Taken
together, these results strongly suggest that SREBP-1a directly
activates expression of the Nlrp1a gene through a binding site in
its proximal promoter.LPS Signaling in Macrophages Activates Lipogenesis
through SREBP-1a
A recent report showed that LPS stimulated de novo lipogenesis
in macrophages in vivo (Posokhova et al., 2008). SREBP-1c is
a key activator of lipogenesis in liver, where it is the major
SREBP-1 species (Horton et al., 2002), so we tested the idea
that SREBP-1a might stimulate lipogenesis in macrophages in
response to LPS where it is the more abundant SREBP-1 iso-
form. In Figure 7A, we show that de novo lipogenesis in BMDM
is increased by LPS in WT but not SREBP-1aDF macrophages.
LPS also stimulated accumulation of SREBP-1 nuclear protein
(Figure 7B) and mRNA levels (Figure 7D), but SREBP-1c mRNA
was not affected. These results strongly support that LPS stim-
ulates lipogenesis through SREBP-1a in BMDM.
In prior studies, we noted the presence of two binding sites for
Sp1 flanking one NF-kB site in the SREBP-1a promoter (Fig-
ure 7C) (Zhang et al., 2005). NF-kB is a key downstream trans-
ducer of LPS signaling, and so we tested the idea that the
LPS-dependent increase in mRNA might be direcly through
NF-kB recruitment to the SREBP-1a promoter. ChIP studies
with an antibody to the p62 subunit of NF-kB confirmed this
prediction (Figure 7D). NF-kB activates promoters by enhancing
Sp1 corecruitment (Perkins et al., 1993), and because there are
two functional Sp1 sites in the SREBP-1a promoter, we also per-
formed ChIP with an antibody to Sp1. Interestingly, Sp1 recruit-
ment was also enhanced by LPS treatment (Figure 7E). These
results provide strong evidence that in macrophages LPS stim-
ulates lipogenesis through increasing NF-kB/Sp1 synergistic
activation of the SREBP-1a promoter.ell Metabolism 13, 540–549, May 4, 2011 ª2011 Elsevier Inc. 543
Figure 4. SREBP-1a Regulates Nlrp1a Expression Level in BMDM
(A) DNAmicroarray analysis of gene expression in BMDMofWT and SREBP-1aDFmice (n = 9, pooled threemice for each group). The heatmap represents genes
showing a statistically significant 2-fold or greater induction in WT as well as a 2-fold or difference in expression from SREBP-1aDF compared to WT mice. (B)
Representative values from themicroarray, NC indicates no change. Expression of Nlrp1a (C) or Nlrp1c (D) was confirmed by qPCR. Data aremean ± SD; n = 3 for
three separate experiments. *WT versus SREBP-1aDF, p = 0.0052; **WT versus SREBP-1aDF, p = 0.0049.
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In the current study, we show that SREBP-1a-deficient mice
have an impaired innate immune response in vivo, and we
show SREBP-1a is required to activate caspase-1 and stimulate
both IL-1b production and lipogenesis in response to LPS
challenge in isolated macrophages. These results with cultured
macrophages provide a mechanism for the impaired innate
immune response in the SREBP-1aDF mice.
An intriguing question is why SREBP-1a, a key lipogenic
transcription factor, evolved to also directly regulate genes of
the innate immune response in macrophages? This is likely
because cell proliferation and membrane expansion/rearrange-
ments are both essential in the macrophage response to path-
ogen challenge and both require new lipid synthesis. Consistent
with this idea, LPS was recently shown to increase de novo
lipogenesis in macrophages in vivo (Posokhova et al., 2008).
Interestingly, our experiments show that LPS stimulates lipogen-
esis inWT but not SREBP-1aDFmacrophages (Figure 7), andwe544 Cell Metabolism 13, 540–549, May 4, 2011 ª2011 Elsevier Inc.also show that SREBP-1a activates expression of key lipogenic
genes in macrophages as well as Nlrp1a in response to macro-
phage lipid depletion (Figure S5).
Our studies show that SREBP-1a is required for LPS-stimu-
lated IL-1b production and that this is likely through SREBP-1a
activating expression of the gene encoding Nlrp1a, which is
a mouse ortholog of human Nlrp1. Human Nlrp1 is part of
a protein complex called an inflammasome that is required to
activate caspase-1 to cleave proinflammatory cytokines such
as IL-1b during the proinflammatory response (Martinon et al.,
2007). Nlrp1a expression, caspase-1 activity, and IL-1b produc-
tion were all dramatically reduced in SREBP-1aDF macro-
phages. Because we observed a similar phenotype when we
knocked down Nlrp1a in WT macrophages using siRNA, the
effect is unlikely to be a result of another consequence of
the SREBP-1a deficiency.
SREBP-1a mRNA and nuclear protein levels were also both
increased following LPS treatment (Figure 7). This response is
probably through NF-kB activating expression of SREBP-1a
Figure 5. LPS-Mediated IL-1b Production Is Decreased in SREBP-
1aDF Macrophages
BMDMs were treated with 50 ng/ml LPS for the indicated times and collected
for analysis.
(A) Caspase-1 activity was measured on cell extracts and normalized for zero
time for each sample. xWT versus 1aDF at 6 hr, p = 0.008.
(B) Macrophages were stimulated with LPS (50 ng/ml) for 6 hr, followed by
incubation with or without 1 mM ATP for 30 min. IL-1b released into the
medium was measured by ELISA *WT versus SREBP-1aDF, p = 0.038,
**WT versus SREBP-1aDF, p = 0.007.
(C) IL-1b release from BMDM after infections with S. typhimurium. BMDMs
fromSREBP-1aDF orWTmice were infected withS. typhimurium (moi = 10) for
24 hr. Data are shown as geometric means (bars) from three experiments ± the
standard errors. #moi = 10; p = 0.004.
(D) si-RNA targeting Nlrp1a, Nlrp3, or a control siRNA (Nci) (100 pmol) was
added to macrophages that were subsequently treated with LPS (200 ng/ml)
for 6 hr and then pulsed with 1 mM ATP for 30 min. IL-1b was measured as
above.
(E and F) Nlrp1a or Nlrp3 RNA levels were measured in samples from (D).
(G) SREBP-1aDFmacrophageswere electroporatedwith vector (pcDNA) or an
expression construct encoding SREBP-1a (SR-1a) as described in the
Experimental Procedures and incubated with LPS ± ATP, and secreted levels
of IL-1b were measured as above.
Figure 6. SREBP-1a Activates and Binds to Nlrp1a Promoter
(A and B) mRNA expression for Nlrp1a (A) or Nlrp1c (B) gene expression in
BMDM. BMDMs in 100 mm dishes were infected with Ad-GFP or Ad-SREBP-
1a (10 moi) for 24 hr, and RNA was extracted and Nlrp1a or Nlrp1c expression
was analyzed by qPCR and normalized using L32. zad-GFP versus ad-1a in
SREBP-1aDF BMDM, p = 0.0391.
(C) There is a SREBP element in the Nlrp1a promoter between 358 bp
and 351 bp.
(D and E) Deletion constructs for the Nlrp1a promoter were analyzed for
promoter activity; an internal control expression plasmid for b-galactosidase
driven by a CMV promoter was used for normalization. Letters refer to
diagrams in (C), *pGLM versus p-1208 after transfected SREBP-1a,
p = 0.0018; **p-1208 versus p-208 after transfected SREBP-1a, p = 0.0006.
(F) Chromatin from BMDM was analyzed for recruitment of SREBP-1 to the
SRE region of Nlrp1a promoter by ChIP as described in the Experimental
Procedures (filled arrows in Figure 3C). #anti-IgG versus anti-SR1, p = 0.02.
(G) As a negative control, we used primers for a non-SRE region for PCR
(dashed arrows in Figure 3C). DNA in the precipitation with SREBP-1 antibody
was normalized to input and plotted relative to the IgG background. Data are
mean ± SD; n = 3 for three separate experiments.
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Figure 7. SREBP-1a Activates Lipogenesis and Is a Proinflammatory
Gene in BMDM
(A) De novo fatty acid biosynthesis was measured before or after LPS stimu-
lation. xWT versus 1aDF at 6 hr, p = 0.008.
(B) Nuclear protein was analyzed for SREBP-1 by immunoblotting, and
a-tubulin was used as normalization control; nSREBP-1 denotes nuclear
SREBP-1.
(C) Schematic diagram for SREBP-1a promoter (arrows denote location of
primers used for ChIP). AnNF-kBbinding site is located between two Sp1 sites
in the SREBP-1a promoter. BMDMs were cultured in control medium or
treated with LPS (100 ng/ml) for 24 hr.
(D) RNA was analyzed by qPCR for SRBEP-1a or -1c as indicated. L32 were
used as normalization control. RNA analyses were performed in triplicate and
are expressed as the mean ± SD #LPS-treated versus untreated group in WT,
p = 0.05.
(E) ChIP analysis. *LPS-treated versus untreated group in NF-kB; p = 0.026,
**LPS-treated versus untreated group in Sp1; p = 0.003.
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production of mature SREBP-1 protein is probably driven by
increased synthesis of the ER targeted precursor, because in
other settings where SREBP gene expression is increased there
is also an elevation of nuclear SREBP levels (Repa et al., 2000;
Shin and Osborne, 2003).
Nlrp1a mRNA was not further induced by LPS in WT macro-
phages (Figure S4B), which is likely because the basal SREBP-
1a levels in macrophages are sufficient and further induction is
both not required and limited by other factors. This is not unex-
pected, as our results also show that known SREBP-1 target546 Cell Metabolism 13, 540–549, May 4, 2011 ª2011 Elsevier Inc.genes involved in lipid metabolism are also differentially affected
by genetic and metabolic conditions that alter SREBP-1a levels
(Figure S5), and knockout and pharmacological studies of
nuclear receptors show similar differential effects on subsets of
target genes (Wagner et al., 2003).
Earlier studies demonstrated that a knockout of Nlrp3
decreased LPS-mediated IL-1b production. However, the
response to S. typhimurium challenge was normal (Sutterwala
et al., 2006), indicating that an inflammasome composed of
other Nlrp family members must be involved. A more recent
study indicated that both Nlrp3 and Nlrc4 have redundant roles
in host defense against S. typhimurium, suggesting that
multiple Nlrs play a cooperative role in host defense against
intracellular pathogens (Broz et al., 2010). Because IL-1b
production after S. typhimurium challenge was reduced in the
SREBP-1aDF macrophages, our results suggest that Nlrp1a
may be an additional component of this inflammasome. Using
siRNA knockdown of both Nlrp1a and Nlrp3, we also showed
that both contribute to LPS-dependent IL-1b production
(Figure 5).
There was reduced mortality in the SREBP-1aDF mice
following both LPS and CLP challenge. These are two situations
in which a hyperinflammatory response is lethal. SREBP-1aDF
mice also secreted lower levels of IL-1b following LPS injection
andCLP treatment. Themutantmicewere alsomore susceptible
to infection when challengedwith an oral dose ofS. typhimurium,
consistent with the reduced ability of the SREBP-1aDF mice to
effectively mount an anti-inflammatory response to bacterial
infection. These results are similar to another report in which
S. typhimurium infection caused more edema, neutrophil infiltra-
tion, and epithelial destruction in the cecum of caspase-1
knockout mice (Lara-Tejero et al., 2006). Despite the increased
inflammatory response in this study, there was no difference in
cecal levels of S. typhimurium in caspase-1/ versus wild-
type mice at 48 hr postinfection. Similar to this study, we found
reduced colonization by S. typhimurium in the cecum of
SREBP-1a DF mice at 72 hr postinfection (Figure 2G).
IL-1b knockout mice are not resistant to a lethal LPS challenge
(Fantuzzi et al., 1996),whereas caspase-1-deficientmiceare pro-
tected similar to the SREBP-1aDF animals (Li et al., 1995). Thus,
the reason for the increased resistance in the SREBP-1aDFmice
is likely due to more than just reduced IL-1b production. Indeed,
there is evidence that Nlrp1 deficiency results in lower levels of
IL-12 production (Witola et al., 2010), and mice deficient in the
p40 subunit that is shared between IL-12 and IL-23 have an
altered response to CLP (Moreno et al., 2006). Because the
SREBP-1aDF mice also have reduced serum levels of IL-12
following LPS challenge, it is possible that at least part of the
reason they aremore resistant is because of lower levels of IL-12.
All of the in vivo responses suggested there was an altered
innate immune response, and our more focused studies demon-
strate there was an impaired inflammatory response in the
SREBP-1aDF macrophages, which provides a mechanism for
the in vivo effects. However, because the whole animal setting
is much more complicated and the model is a global knockout
of SREBP-1a, it is possible that the in vivo response may be
more complex and warrants further study.
Mice lacking the inflammasome adaptor ASC are completely
resistant to challenge by very high concentrations of LPS
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Nlrp3 knockout (Sutterwala et al., 2006), are only partially resis-
tant. This suggests that inflammasomes containing ASC are
crucial to the proinflammatory response in vivo and that the func-
tions for Nlrp1a and Nlrp3 might be partially redundant and the
results from our siRNA knockdown studies of Nlrp1a and Nlrp3
are consistent with this hypothesis (Figure 5D).
Different NLRs have been proposed to channel caspase-1 into
pathways required for different physiological responses
(Schroder and Tschopp, 2010). These include inflammation in
response to LPS (Sutterwala et al., 2006), protection from lethal
toxin produced by B. anthracis (Boyden and Dietrich, 2006),
activation of cell death by S. typhimurium (Mariathasan et al.,
2004), and a distinct caspase-1-dependent pathway for
apoptosis in response to bacterial pore-forming toxins that
also requires SREBPs (Gurcel et al., 2006). This is also consistent
with results from other recent studies suggesting there may be
multiple inflammasomes that are constituted with different
combinations of individual Nlrp species (Broz et al., 2010;
Wu et al., 2010).
Production of mature IL-18 is also stimulated by an inflamma-
some/caspase-1-dependent mechanism (Gu et al., 1997).
However, IL-18 levels were not affected in LPS-challenged
SREBP-1aDF mice (Figure S2). This was not completely unex-
pected based on other reports in which secretion of IL-1b and
IL-18 can be uncoupled. In one study, lethal toxin from
B. anthracis stimulated macrophage production of both IL-18
and IL-1b, whereas LPS stimulation resulted in production of
IL-1b, but not IL-18 (Cordoba-Rodriguez et al., 2004). Another
study also showed that LPS stimulated release of IL-1b from
human monocytes, but there was no effect on IL-18 (Kankkunen
et al., 2009).
In macrophages, the nuclear receptor LXR activates genes
involved in cholesterol efflux and reverse cholesterol transport
to limit macrophage cholesterol accumulation (Laffitte et al.,
2001; Venkateswaran et al., 2000). Additionally, LXR and
PPAR-g signaling in macrophages limits inflammation by inhibit-
ing NF-kB (Ghisletti et al., 2007; Joseph et al., 2003; Welch et al.,
2003). These effects are predicted to attenuate the proinflamma-
tory response and would be beneficial in preventing accumula-
tion of lipid inmacrophages during critical times such as the early
stages of atherosclerotic plaque deposition where inflammatory
signaling contributes to the severity of lesion development and
progression (Lusis, 2000; Ross, 1999).
Our studies show that SREBP inflammation crosstalk is impor-
tant for the initial proinflammatory response, which requires new
lipid synthesis for membrane expansion and proliferation.
SREBPs predate nuclear receptors in evolution, and their coevo-
lution with the proinflammatory response is likely a more primi-
tive response that occurred to couple lipid production to survival
pathways in response to pathogen challenge.
EXPERIMENTAL PROCEDURES
Animals
SREBP-1a-deficient mice (SREBP-1aDF) were described previously (Im et al.,
2009). Mice were maintained in 12 hr light/12 hr dark cycles with free access to
food and water. All procedures were performed in accordance with the Institu-
tional Animal Care and Use Committees at the University of California Irvine
and the Sanford-Burnham Medical Research Institute at Lake Nona.CMouse Bone Marrow-Derived Macrophages
Bone marrow-derived macrophages were isolated from either C57BL/6 or
SREBP-1aDF essentially as described (Gilchrist et al., 2006). After
7–10 days in culture, the differentiation of BMDMs were confirmed by FACS
analysis using anti-CD11b, and there was no difference in differentiation
betweenWT and SREBP-1aDF cells. BMDMs were then used for experiments
as described below and in the figure legends (Joshi et al., 2008).
Cytokine ELISA Measurements
BMDMs (2 3 104/well) were plated in 24-well plates and incubated with
100 ng/ml LPS or 50 ng/ml LPS for various times, and then culture superna-
tants were assayed for IL-1b by ELISA (R&D Systems). Where indicated,
1mMATPwas added 30min prior to sampling the supernatant. For measuring
serum cytokine levels in mice, 8- to 10-week-old male mice (WT or SREBP-
1aDF) were used. LPS (Escherichia coli serotype 055:B5; Sigma) was sus-
pended in endotoxin-free PBS and vigorously mixed for 15 min before use.
A single dose of LPS was injected intraperitoneally into mice (10 mg/kg
body weight), blood was collected after the indicated times, and cytokine
levels were measured in serum using a commercial mouse IL-1b inflammatory
cytokine ELISA kit (R&D Systems).
Caspase-1 Activity Assay
BMDMs were cultured as above and a caspase-1 enzymatic assay using
YVAD-AFC (AFC, 7-amino-4-trifluoromethyl coumarin) as substrate was
used (Biovision, Palo Alto, CA). Fluorometric readings were performed over
a 30 min period at a wavelength pair of 400/505 nm excitation/emission, using
a Spectramax M5 plate reader (Molecular Devices, Sunnyvale, CA). Kinetic
analysis (determination of Vmax) of AFC fluorescence was used to calculate
enzymatic activity, which was normalized by protein content and expressed
as fold increase over the basal level (unstimulated cells).
Adenovirus Infection in Bone Marrow-Derived Macrophages In Vitro
Macrophages were seeded in 100 mm dishes (5 3 106 cells/dish). Recombi-
nant adenovirus (10 multiplicities of infection [moi]) was added to cultures in
DMEM medium including 15% L929 conditioned medium without FBS at
37Cwith 5%CO2 for 6 hr, and thenmedium (plus FBS) was added back. After
a further 24 hr incubation, cells were harvested for analysis.
Endotoxicosis and Cecal Ligation and Puncture
Male WT or SREBP-1aDF mice (8- to 10-week old; n = 10 per each genotype)
were injected with 10 mg/kg of LPS, and animals were monitored for 7 days.
For induction of polymicrobial sepsis, mice (n = 10 per each genotype group)
underwent CLP or a sham procedure, as previously described (Delano et al.,
2007). Briefly, a laparotomy was performed under general anesthesia, the
cecum was isolated, and 0.5 cm of cecum was ligated below the ileocecal
valve and adistal region punctured all theway through one timewith a 23gauge
needle. Sham operation was performed by isolating the cecumwithout ligation
or puncture. Blood was collected after 24 hr and IL-1b levels were measured
by ELISA (SABiosciences) as described above.
S. typhimurium Infection of Mice and BMDM
BMDMs prepared as above were seeded at a concentration of 23 106 cells/ml
in 24-well plates. A nalidixic acid-resistantderivative ofSalmonella typhimurium
ATCC14028 was grown overnight static in Luria-Bertani (LB) broth. BMDMs
were infected with S. typhimurium with moi of 1 and 10 and were incubated
at 37C 5% CO2. To kill extracellular bacteria, the supernatant was replaced
with media containing gentamicin at a concentration of 100 mg/ml 1 hr postin-
fection, and bymedia with a lower concentration of gentamicin (25 mg/ml) after
an additional hour. Cells were incubated overnight, and supernatant was
analyzed for IL-1b by ELISA (eBioscience). The experiment was repeated
five times with similar results. For the mouse experiments, groups of six
SREBP-1aDF or C57/B6 mice were infected with 1 3 109 CFUs of
S. typhimurium 24 hr after treatment with streptomycin as previously
described (Raffatellu et al., 2009). At 72 hr after infection, the cecum was
collected as described (Raffatellu et al., 2009). S. typhimurium colonization
of the cecum was measured by collecting the cecal content, which was
weighed and resuspended by vigorous shaking in 1 ml of phosphate-buffered
saline for 15 min. The colony-forming units were enumerated by plating serialell Metabolism 13, 540–549, May 4, 2011 ª2011 Elsevier Inc. 547
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were normalized by the weight of the cecal content collected from each
mouse, which varied between 15 and 60 mg. This experiment was repeated
three times with similar results.
Introduction of si-RNA for Nlrp1a and Nlrp3 into Bone
Marrow-Derived Macrophages
WT BMDMs (2 3 106 cells), 100 ml of Nucleofector solution and 100 pmol of
smart pool siRNA for Nlrp1a, Nlrp3, or a negative control (Dharmacon) were
mixed into a cuvette for the Amaxa Nucleofector, and samples were electro-
porated with program Y-001 designed by the manufacturer. Following electro-
poration, cells were seeded onto 12 cm dishes. Forty hours after transfection,
cells were stimulated with LPS (200 ng/ml) for 6 hr followed by addition of ATP
(1 mM) for 30 min. Cultured media were collected to measure IL-1b by ELISA,
and cells were harvested with Trizol (Invitrogen) for isolation of RNA. The
smart pool strategy decreases off-target effects and increases specificity
as described (http://www.dharmacon.com/uploadedFiles/Home/Resources/
Product_Literature/smartpool-tech-note.pdf).
RNA Isolation and Quantitative Real-Time Polymerase
Chain Reaction
Total RNA was isolated from macrophages of WT and SREBP-1aDF mice
using the Trizol method (Invitrogen). cDNA was synthesized by cDNA super-
script kit (Bio-Rad) and used for qPCR with Real-Time PCR Detection
(Bio-Rad). mRNA levels were normalized for expression of ribosomal protein
L32 mRNA as control and calculated by the comparative threshold cycle
method. Plasmids containing partial cDNAs for SREBP-1a, -1c, and -2 that
encompass the oligonucleotides used for PCR were isolated, and the purified
DNA was quantified by A260. Serial dilutions of the plasmid DNAs were
included in each qPCR analysis for use as a standard curve for quantitation.
All qPCR reactions were repeated in triplicate. All primers were designed to
amplify RNA across intron junctions, and the melting curves in the qPCR reac-
tions all showed a simplemelting curve indicative of a single amplified product.
qPCR primer sequences were either as described in Table S1 or as published
(Im et al., 2009).
Immunoblotting
Nuclear extracts were prepared from BMDM of WT and SREBP-1aDF mice.
Immunoblottingwasperformed following amodified protocol basedon aprevi-
ously described method (Sheng et al., 1995). Nuclear proteins were resolved
by 8% Tris-HCl SDS/PAGE gel electrophoresis and transferred onto nitrocel-
lulose (Bio-Rad). All immunoblots were developed using HRP-conjugated
secondary antibody with an ECL detection system (GE Healthcare).
Biosynthesis of Fatty Acids
BMDMs were treated with LPS as described in the text. Cell media was
removed from the plates, which were then incubated in fresh medium with
sodium [14C] acetate for 6 hr. After washing labeled cells, cells were dissolved
by 0.1 NNaOH. Prior to saponification, 500 ul of 75%KOH, 10 ul of [3H] choles-
terol nonsaponified TLC recovery carrier solution, and 10 ul [3H]oleic acid
carrier solution was added to each sample. After extraction with petroleum
ether, the fatty acid fraction was dried under nitrogen gas and dissolved in
30 ul of choloroform for fatty acid. Extract samples were spotted onto
plastic-backed silica gel TLC plates and stained the TLC plates with iodine
vapor. Excise spots were excised and put in scintillation vials including
10 ml scintillation solution to count [14C] and [3H].
Statistical Analysis
Three to five experiments of all studies were performed, using triplicate repli-
cations of each sample. The data are represented as mean ± SD. All data sets
were analyzed for statistical significance using a two-tailed unpaired Student’s
t test. All p values below 0.05 were considered significant. Statistical analysis
was carried out using Microsoft Excel (Microsoft).
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